SNX2
Basic information
Region (hg38): 5:122775079-122834543
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SNX2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 18 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 0 | 0 |
Variants in SNX2
This is a list of pathogenic ClinVar variants found in the SNX2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-122775108-C-T | not specified | Uncertain significance (Jul 16, 2024) | ||
5-122775115-G-C | not specified | Uncertain significance (Jun 23, 2021) | ||
5-122775117-G-A | not specified | Uncertain significance (Mar 23, 2023) | ||
5-122775119-G-A | not specified | Uncertain significance (Jun 02, 2023) | ||
5-122775123-C-G | not specified | Uncertain significance (Feb 21, 2024) | ||
5-122775135-G-T | not specified | Uncertain significance (Jun 27, 2022) | ||
5-122775140-G-A | not specified | Uncertain significance (Jun 12, 2023) | ||
5-122775167-G-A | not specified | Uncertain significance (Mar 20, 2023) | ||
5-122799730-G-A | not specified | Uncertain significance (Jan 31, 2023) | ||
5-122799734-C-T | not specified | Uncertain significance (May 01, 2024) | ||
5-122799770-C-T | not specified | Uncertain significance (Sep 21, 2023) | ||
5-122799829-G-A | not specified | Uncertain significance (Jul 16, 2024) | ||
5-122801878-G-A | not specified | Uncertain significance (Mar 30, 2024) | ||
5-122801900-A-T | not specified | Uncertain significance (Jul 25, 2023) | ||
5-122803505-T-A | not specified | Uncertain significance (Jun 28, 2022) | ||
5-122815904-A-G | not specified | Uncertain significance (Nov 28, 2023) | ||
5-122816942-C-G | not specified | Uncertain significance (Jan 04, 2024) | ||
5-122816985-A-G | not specified | Uncertain significance (May 01, 2024) | ||
5-122817371-A-G | not specified | Uncertain significance (Aug 15, 2024) | ||
5-122818879-T-A | not specified | Uncertain significance (Nov 17, 2022) | ||
5-122818946-C-A | not specified | Uncertain significance (Jul 27, 2024) | ||
5-122818971-A-G | not specified | Uncertain significance (May 15, 2023) | ||
5-122819018-G-C | not specified | Uncertain significance (Aug 14, 2024) | ||
5-122826050-G-A | not specified | Uncertain significance (Dec 16, 2023) | ||
5-122827392-T-C | not specified | Uncertain significance (Apr 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SNX2 | protein_coding | protein_coding | ENST00000379516 | 15 | 55113 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.985 | 0.0154 | 125720 | 0 | 14 | 125734 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.596 | 238 | 265 | 0.897 | 0.0000126 | 3417 |
Missense in Polyphen | 94 | 99.337 | 0.94627 | 1310 | ||
Synonymous | -0.500 | 96 | 90.0 | 1.07 | 0.00000467 | 944 |
Loss of Function | 4.43 | 4 | 30.3 | 0.132 | 0.00000152 | 383 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000981 | 0.0000967 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000659 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in several stages of intracellular trafficking. Interacts with membranes containing phosphatidylinositol 3- phosphate (PtdIns(3P)) or phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2) (PubMed:16179610). Acts in part as component of the retromer membrane-deforming SNX-BAR subcomplex (PubMed:17101778). The SNX-BAR retromer mediates retrograde transport of cargo proteins from endosomes to the trans-Golgi network (TGN) and is involved in endosome-to-plasma membrane transport for cargo protein recycling. The SNX-BAR subcomplex functions to deform the donor membrane into a tubular profile called endosome-to-TGN transport carrier (ETC) (Probable). Can sense membrane curvature and has in vitro vesicle-to-membrane remodeling activity (PubMed:23085988). Required for retrograde endosome-to-TGN transport of TGN38 (PubMed:20138391). Promotes KALRN- and RHOG-dependent but retromer-independent membrane remodeling such as lamellipodium formation; the function is dependent on GEF activity of KALRN (PubMed:20604901). {ECO:0000269|PubMed:16179610, ECO:0000269|PubMed:17101778, ECO:0000269|PubMed:20138391, ECO:0000269|PubMed:20604901, ECO:0000269|PubMed:23085988, ECO:0000303|PubMed:16179610}.;
- Pathway
- Endocytosis - Homo sapiens (human);Golgi Associated Vesicle Biogenesis;Clathrin derived vesicle budding;trans-Golgi Network Vesicle Budding;Vesicle-mediated transport;Membrane Trafficking;TGF_beta_Receptor;PAR1-mediated thrombin signaling events
(Consensus)
Recessive Scores
- pRec
- 0.132
Intolerance Scores
- loftool
- 0.370
- rvis_EVS
- -0.69
- rvis_percentile_EVS
- 14.97
Haploinsufficiency Scores
- pHI
- 0.339
- hipred
- Y
- hipred_score
- 0.783
- ghis
- 0.674
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.349
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Snx2
- Phenotype
- embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; craniofacial phenotype;
Gene ontology
- Biological process
- intracellular protein transport;endocytosis;early endosome to Golgi transport;retrograde transport, endosome to Golgi;protein complex oligomerization;lamellipodium morphogenesis
- Cellular component
- cytoplasm;lysosome;endosome;cytosol;endosome membrane;membrane;lamellipodium;retromer complex;retromer, tubulation complex;early endosome membrane;protein-containing complex
- Molecular function
- epidermal growth factor receptor binding;insulin receptor binding;protein binding;phosphatidylinositol binding;protein homodimerization activity;cadherin binding;protein heterodimerization activity;transferrin receptor binding;leptin receptor binding